(Q87254595)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

7

Wim E Hennink

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Cornelis J. M. Melief

8

object named as

Cornelis J M Melief

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

5

Jan W Drijfhout

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Marieke F Fransen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Robert A Cordfunke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Marjolein Sluijter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mies J van Steenbergen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ferry Ossendorp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

7 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1654-1660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Incomplete differentiation of antigen-specific CD8 T cells in tumor-draining lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Is cancer dangerous to the immune system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Strategies for immunotherapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Cancer immunotherapy by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Polymer microspheres for controlled drug release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

The origins and evolution of "controlled" drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Issues in long-term protein delivery using biodegradable microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Microgels and microcapsules in peptide and protein drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Modeling of diffusion controlled drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Dextran conjugates in drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Dextrans for targeted and sustained delivery of therapeutic and imaging agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Therapeutic efficacy of IL-2-loaded hydrogels in a mouse tumor model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

In vitro degradation behavior of microspheres based on cross-linked dextran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Controlled release of a model protein from enzymatically degrading dextran microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Clinical application of a new method for the determination of aminoacylase in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

In vivo biocompatibility of dextran-based hydrogels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Cancer-related inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

On the dual roles and polarized phenotypes of neutrophils in tumor development and progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

The splitting of dextran and isomaltose by animal tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

THE METABOLISM OF TUMORS IN THE BODY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.01.056

10.1016/J.VACCINE.2014.01.056

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508038%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference